Report Detail
Global Animal Antibacterial Peptide Market Insights, Forecast to 2025
- RnM2708100 |
- 07 May, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Peptides are derived from animal source and possess antibacterial activity that comes under animal antibacterial peptides. They contain residue of amino acids generally about 15 to 45. Antibacterial peptides are the effector molecules of innate immunity. Majority of the antibacterial peptides are cationic in nature. In insects, the cecropin type of linear peptide without cysteine are found. Now, more than 900 sequences of proteins and antibacterial peptides from plants and animals are stored in database. The antibacterial peptides are broad spectrum in activity. The antibacterial peptides are amphipathic in structure and contains positive charge.
The global Animal Antibacterial Peptide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Animal Antibacterial Peptide market based on company, product type, end user and key regions.
This report studies the global market size of Animal Antibacterial Peptide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Animal Antibacterial Peptide in these regions.
This research report categorizes the global Animal Antibacterial Peptide market by top players/brands, region, type and end user. This report also studies the global Animal Antibacterial Peptide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merial
Zoetis
Bayer HealthCare
Merck Animal Health
Elanco (Eli Lilly and Company)
Biogenesis Bago
Animal Medics
Boehringer Ingelheim Vetmedica
Market size by Product
Anionic Peptides
Anionic & Cationic Peptides
Cationic Peptide
Linear Cationic - Helical Peptides
Market size by End User
Sheep
Pig
Cattle
Horse
Poultry
Goat
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Animal Antibacterial Peptide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Animal Antibacterial Peptide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Animal Antibacterial Peptide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Animal Antibacterial Peptide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Animal Antibacterial Peptide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal Antibacterial Peptide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Animal Antibacterial Peptide Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Animal Antibacterial Peptide Market Size Growth Rate by Product
- 1.4.2 Anionic Peptides
- 1.4.3 Anionic & Cationic Peptides
- 1.4.4 Cationic Peptide
- 1.4.5 Linear Cationic - Helical Peptides
- 1.5 Market by End User
- 1.5.1 Global Animal Antibacterial Peptide Market Size Growth Rate by End User
- 1.5.2 Sheep
- 1.5.3 Pig
- 1.5.4 Cattle
- 1.5.5 Horse
- 1.5.6 Poultry
- 1.5.7 Goat
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Animal Antibacterial Peptide Market Size
- 2.1.1 Global Animal Antibacterial Peptide Revenue 2014-2025
- 2.1.2 Global Animal Antibacterial Peptide Sales 2014-2025
- 2.2 Animal Antibacterial Peptide Growth Rate by Regions
- 2.2.1 Global Animal Antibacterial Peptide Sales by Regions
- 2.2.2 Global Animal Antibacterial Peptide Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Animal Antibacterial Peptide Sales by Manufacturers
- 3.1.1 Animal Antibacterial Peptide Sales by Manufacturers
- 3.1.2 Animal Antibacterial Peptide Sales Market Share by Manufacturers
- 3.1.3 Global Animal Antibacterial Peptide Market Concentration Ratio (CR5 and HHI)
- 3.2 Animal Antibacterial Peptide Revenue by Manufacturers
- 3.2.1 Animal Antibacterial Peptide Revenue by Manufacturers (2014-2019)
- 3.2.2 Animal Antibacterial Peptide Revenue Share by Manufacturers (2014-2019)
- 3.3 Animal Antibacterial Peptide Price by Manufacturers
- 3.4 Animal Antibacterial Peptide Manufacturing Base Distribution, Product Types
- 3.4.1 Animal Antibacterial Peptide Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Animal Antibacterial Peptide Product Type
- 3.4.3 Date of International Manufacturers Enter into Animal Antibacterial Peptide Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Animal Antibacterial Peptide Sales by Product
- 4.2 Global Animal Antibacterial Peptide Revenue by Product
- 4.3 Animal Antibacterial Peptide Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Animal Antibacterial Peptide Breakdown Data by End User
6 North America
- 6.1 North America Animal Antibacterial Peptide by Countries
- 6.1.1 North America Animal Antibacterial Peptide Sales by Countries
- 6.1.2 North America Animal Antibacterial Peptide Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Animal Antibacterial Peptide by Product
- 6.3 North America Animal Antibacterial Peptide by End User
7 Europe
- 7.1 Europe Animal Antibacterial Peptide by Countries
- 7.1.1 Europe Animal Antibacterial Peptide Sales by Countries
- 7.1.2 Europe Animal Antibacterial Peptide Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Animal Antibacterial Peptide by Product
- 7.3 Europe Animal Antibacterial Peptide by End User
8 Asia Pacific
- 8.1 Asia Pacific Animal Antibacterial Peptide by Countries
- 8.1.1 Asia Pacific Animal Antibacterial Peptide Sales by Countries
- 8.1.2 Asia Pacific Animal Antibacterial Peptide Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Animal Antibacterial Peptide by Product
- 8.3 Asia Pacific Animal Antibacterial Peptide by End User
9 Central & South America
- 9.1 Central & South America Animal Antibacterial Peptide by Countries
- 9.1.1 Central & South America Animal Antibacterial Peptide Sales by Countries
- 9.1.2 Central & South America Animal Antibacterial Peptide Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Animal Antibacterial Peptide by Product
- 9.3 Central & South America Animal Antibacterial Peptide by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Animal Antibacterial Peptide by Countries
- 10.1.1 Middle East and Africa Animal Antibacterial Peptide Sales by Countries
- 10.1.2 Middle East and Africa Animal Antibacterial Peptide Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Animal Antibacterial Peptide by Product
- 10.3 Middle East and Africa Animal Antibacterial Peptide by End User
11 Company Profiles
- 11.1 Merial
- 11.1.1 Merial Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merial Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merial Animal Antibacterial Peptide Products Offered
- 11.1.5 Merial Recent Development
- 11.2 Zoetis
- 11.2.1 Zoetis Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Zoetis Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Zoetis Animal Antibacterial Peptide Products Offered
- 11.2.5 Zoetis Recent Development
- 11.3 Bayer HealthCare
- 11.3.1 Bayer HealthCare Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bayer HealthCare Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bayer HealthCare Animal Antibacterial Peptide Products Offered
- 11.3.5 Bayer HealthCare Recent Development
- 11.4 Merck Animal Health
- 11.4.1 Merck Animal Health Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Merck Animal Health Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Merck Animal Health Animal Antibacterial Peptide Products Offered
- 11.4.5 Merck Animal Health Recent Development
- 11.5 Elanco (Eli Lilly and Company)
- 11.5.1 Elanco (Eli Lilly and Company) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Elanco (Eli Lilly and Company) Animal Antibacterial Peptide Products Offered
- 11.5.5 Elanco (Eli Lilly and Company) Recent Development
- 11.6 Biogenesis Bago
- 11.6.1 Biogenesis Bago Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Biogenesis Bago Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Biogenesis Bago Animal Antibacterial Peptide Products Offered
- 11.6.5 Biogenesis Bago Recent Development
- 11.7 Animal Medics
- 11.7.1 Animal Medics Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Animal Medics Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Animal Medics Animal Antibacterial Peptide Products Offered
- 11.7.5 Animal Medics Recent Development
- 11.8 Boehringer Ingelheim Vetmedica
- 11.8.1 Boehringer Ingelheim Vetmedica Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Boehringer Ingelheim Vetmedica Animal Antibacterial Peptide Products Offered
- 11.8.5 Boehringer Ingelheim Vetmedica Recent Development
12 Future Forecast
- 12.1 Animal Antibacterial Peptide Market Forecast by Regions
- 12.1.1 Global Animal Antibacterial Peptide Sales Forecast by Regions 2019-2025
- 12.1.2 Global Animal Antibacterial Peptide Revenue Forecast by Regions 2019-2025
- 12.2 Animal Antibacterial Peptide Market Forecast by Product
- 12.2.1 Global Animal Antibacterial Peptide Sales Forecast by Product 2019-2025
- 12.2.2 Global Animal Antibacterial Peptide Revenue Forecast by Product 2019-2025
- 12.3 Animal Antibacterial Peptide Market Forecast by End User
- 12.4 North America Animal Antibacterial Peptide Forecast
- 12.5 Europe Animal Antibacterial Peptide Forecast
- 12.6 Asia Pacific Animal Antibacterial Peptide Forecast
- 12.7 Central & South America Animal Antibacterial Peptide Forecast
- 12.8 Middle East and Africa Animal Antibacterial Peptide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Animal Antibacterial Peptide Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Animal Antibacterial Peptide . Industry analysis & Market Report on Animal Antibacterial Peptide is a syndicated market report, published as Global Animal Antibacterial Peptide Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Animal Antibacterial Peptide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
